VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. - Wikidata - wikimedia - TriplyDB

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.

http://www.wikidata.org/entity/Q34254937

about

Metastasis-associated in colon cancer-1 in gastric cancer: Beyond metastasis Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosis Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer Anti-angiogenic therapies for metastatic colorectal cancer: current and future perspectives Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy Mouse models for studying angiogenesis and lymphangiogenesis in cancer Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer Network fingerprint: a knowledge-based characterization of biomedical networks.Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.Generation of homologous cell pairs using the oral lymphatic system Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer Generation of lung adenocarcinoma DNA aptamers for cancer studies.Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells.Runx2-Smad signaling impacts the progression of tumor-induced bone disease VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.The lymph node microenvironment and its role in the progression of metastatic cancer.Angiopoietin-4 increases permeability of blood vessels and promotes lymphatic dilation.Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.Fluid shear promotes chondrosarcoma cell invasion by activating matrix metalloproteinase 12 via IGF-2 and VEGF signaling pathways.A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2.The Lymphatic Endothelial mCLCA1 Antibody Induces Proliferation and Growth of Lymph Node Lymphatic Sinuses.Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles.Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis Systematic high-content genome-wide RNAi screens of endothelial cell migration and morphology.The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.Emerging therapeutic targets in metastatic progression: A focus on breast cancer.Characterization of internodal collecting lymphatic vessel function after surgical removal of an axillary lymph node in mice The Lymphatic System in Disease Processes and Cancer Progression

P2860

Q26740205-69351142-180B-44D7-AFEB-941C94728719 Q26745683-754EB41F-DDEA-4747-AF8C-46FD04709A07 Q26774351-1B7117DC-2A89-4F32-B042-56D3060E91E4 Q26778332-47F77699-5140-4D9F-84A8-3403E4A509A0 Q26826817-4D9902A1-E741-4E09-9A97-7B17E2494398 Q26853604-472C2EB0-4569-45C9-8042-113A2E428A1F Q27003898-A01607CC-48CE-4ED7-9A0C-8A849EA27475 Q27013620-1D5D92F6-8F5F-41EC-9026-FCA052152E6C Q27311384-C0FFF015-84AE-477F-A281-B16ED8A339E4 Q27333172-1AD20AF4-B67D-4DFD-A062-83A43B8EC193 Q28072448-EBE5B81D-A6EF-4F53-BB5C-E142101B728A Q30662482-D683814A-0320-47E8-B825-A2E5F9777B02 Q33555154-59978505-97EE-4993-90D3-67C059F0998F Q33582984-8402701A-8AC4-4DD2-ADBF-6B13A5A1E8B5 Q33699388-9B26C6CD-D199-4AA2-9BDD-7F2BE08A60EA Q33712485-2C446B25-E7F3-4B58-9FF2-13D11D45E739 Q34128977-C1D20D69-4F75-4BA9-A89E-B2D330592107 Q34451865-4D8FA1E5-8431-491F-AB72-8E8989993E3D Q34786543-4462C6DB-ED27-41CD-A8F2-30FCA900D719 Q34898865-C0D49A2E-B492-44BF-B915-0FA1A7F870AB Q35087391-5B0269DD-6DAB-4B56-B375-66C73E43B69B Q35174365-1A9D037F-C5B2-43DE-B607-1E1810D130D1 Q35417958-23759CD3-74E2-43FA-8BD7-289A3227F91E Q35632471-10B9D1ED-7540-489A-B1C1-E93D2F9BADC9 Q35653603-5CA07E3B-4E0A-4204-BDC3-88273418A80C Q35672174-F78A6FF8-9DFB-4C41-B76A-30EE789C76EF Q35695806-29A00064-9003-43BD-8DF8-685E4BBAD251 Q35911030-A656F6D1-03B2-4996-831F-06F4E7241B73 Q35978086-1A68C945-F12C-4F89-B58A-2918D6F22099 Q36029195-6282261C-B9A3-438C-87C3-00E8215EE4CE Q36205937-80729702-AC83-447C-9D0E-ED65B84EF6FC Q36241623-AA30D15C-BB7D-4E0A-9419-C8781D3ABB0C Q36293776-A2386E73-B7BA-4E49-A8B6-A2EAA1EE5396 Q36339264-31F69498-E6BF-45C0-84DA-E591D18E34D1 Q36382124-86BDE219-FC28-428F-81FC-BCFAAAB96B56 Q36534347-5DD8B6B1-CA9F-42EB-8F16-9810F4CA3ACB Q36708521-C7F19497-CD91-4E8C-9C50-5F9988631693 Q36854062-637A1942-3AD1-421D-893C-9C3AC864E7AC Q37057569-C3B75F51-12A0-4CED-8DE3-23FA9909B00E Q37099065-324F97F3-1763-4D7C-8F5F-BB18DE4503E4

P2860

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.

http://www.wikidata.org/entity/Q34254937

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@ast

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@en

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@nl

type

label

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@ast

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@en

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@nl

prefLabel

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@ast

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@en

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@nl

P1433

Q34254937-494B5138-7A12-4580-948A-A6D75B50CC58

P1476

Q34254937-9EF57933-6A80-45F6-A81B-E8C5B487EA1A

P2093

Q34254937-11CDC9BE-E707-42D4-9B10-D5FCAF8ADCF6

Q34254937-3299D2EF-9B16-4DC9-B471-FA0B5A8BE88B

Q34254937-3A288E7B-4261-442E-BC79-EA3A85F2DCF9

Q34254937-5A2E4E2E-F95F-4A7C-9693-3C2EFB0F40FB

Q34254937-64E078CD-59CE-4B15-B6AF-FF639B82F82E

Q34254937-8B299B58-845B-4429-834D-B774684C0337

Q34254937-8C8868E9-C468-415B-87CC-BA9878A8A8C5

Q34254937-91E9A591-C744-4D94-ABBD-B3B119F16E00

Q34254937-A23884B4-473A-453D-A165-8C6EF54E23D3

Q34254937-BC61FF05-11AB-406F-A094-0C8F7B571A07

P304

Q34254937-E6918DE1-7492-42EE-A5F0-71B1D9E3924B

P31

Q34254937-12CF2839-1DD8-48E4-9B18-5A90212EEB82

P356

Q34254937-45DE6AE4-B73F-4F32-A580-E6CA1298EBFA

P433

Q34254937-27A90D58-242A-47A1-9769-C1006B93D394

P478

Q34254937-3AE4D983-1FB7-48A1-82E7-90ABAFBE51B5

P50

Q34254937-6BE2CD53-AE6B-4E80-91DD-4038CE4FB3B8

P577

Q34254937-BE6C80A9-E3EA-4DF0-B3C5-D8DDE6E02D83

P5875

Q34254937-F8915717-E695-40C2-87CC-B4DF16292AC9

P698

Q34254937-B3D341FC-D75B-4966-A2D4-1012A6A4E215

P921

Q34254937-3CB88639-01B3-4F7C-8CDE-22CE3C0699EE

P356

J.CCR.2011.12.026

P1433

P1476

VEGF-D promotes tumor metastas ...... lecting lymphatic endothelium.

@en

P2093

Carol Caesar

http://www.w3.org/2001/XMLSchema#string

Dedreia L Tull

http://www.w3.org/2001/XMLSchema#string

Erica K Sloan

http://www.w3.org/2001/XMLSchema#string

Kathryn Ardipradja

http://www.w3.org/2001/XMLSchema#string

Marc G Achen

http://www.w3.org/2001/XMLSchema#string

Megan E Baldwin

http://www.w3.org/2001/XMLSchema#string

Ming G Chai

http://www.w3.org/2001/XMLSchema#string

Nicole C Harris

http://www.w3.org/2001/XMLSchema#string

Rae H Farnsworth

http://www.w3.org/2001/XMLSchema#string

Ramin Shayan

http://www.w3.org/2001/XMLSchema#string

P304

181-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2011.12.026

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221838188

http://www.w3.org/2001/XMLSchema#string

P698

22340592

http://www.w3.org/2001/XMLSchema#string

P921